Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
High-dose chemotherapy improved survival in breast cancer patients
February 16th, 2006
Use of high-dose chemotherapy improved survival in breast cancer patients when compared with a dose-dense conventional regimen. According to recent research from Germany, "Breast cancer with extensive axillary-lymph-node involvement has a poor prognosis after conventional treatment. In trials with historical controls, high-dose chemotherapy produced improved outcomes." "We compared an intensive double-cycle high-dose chemotherapy regimen with an accelerated conventionally dosed regimen in high-risk breast cancer in a multicenter trial. Patients with at least 9 positive nodes were randomly assigned either 2 courses of accelerated (2-week intervals,...
Source: Women's Health Weekly (2006-02-16)
|
